Related by context. All words. (Click for frequent words.) 64 VADT 62 Digital Mammographic Imaging 62 Screening Trial DMIST 62 APOE genotype 62 recurrent miscarriage 61 operable breast cancer 61 BRCA mutation 61 testosterone supplementation 61 prospective longitudinal 61 prostate cancer CaP 61 randomized controlled trials RCTs 61 chlamydial infection 60 GnRH agonists 60 Subgroup analyzes 60 multivariate analyzes 60 neurodevelopmental outcomes 60 STEP BD 60 perinatal outcomes 59 warfarin therapy 59 thrombophilia 59 abnormal mammograms 59 Multiple logistic regression 59 advanced neoplasia 59 Li Fraumeni 59 nulliparous women 59 abnormal Pap test 59 guideline concordant 59 PLCO 59 antioxidant supplementation 59 postmenopausal hormone therapy 59 abnormal Pap smear 59 ICD implantation 59 KRAS mutation 59 EGFR mutation status 59 APEX AMI trial 58 tumor histology 58 undergoing radical prostatectomy 58 T1DM 58 nonadherence 58 intravenous bisphosphonates 58 prognostic indicators 58 familial pancreatic cancer 58 Meta analyzes 58 adjuvant radiotherapy 58 symptomatic fibroids 58 psychiatric comorbidities 58 pharmacogenetic testing 58 DHEA supplementation 58 sociodemographic characteristics 58 prophylactic mastectomies 58 BARI 2D 58 atypical femur fractures 58 #F FDG PET 58 liver biopsies 58 cerebral microbleeds 58 HF ACTION 58 postoperative radiotherapy 57 endoscopists 57 elevated CRP 57 colorectal liver metastases 57 peritoneal cancer 57 preventive mastectomies 57 hereditary breast 57 SCD HeFT 57 bivariate analyzes 57 pelvic ultrasound 57 beta blocker therapy 57 postoperative atrial fibrillation 57 endoscopic examinations 57 invasive lobular carcinoma 57 thiopurine 57 SLNB 57 postoperative mortality 57 non pharmacological interventions 57 abnormal mammogram 57 oral bisphosphonate 57 screening colonoscopy 57 core needle biopsies 57 VCUG 57 Heavy menstrual bleeding 57 clinical pharmacology studies 57 BRCA mutation carriers 57 oncologic outcomes 57 Alequel 57 carotid stenosis 57 multivariable analyzes 57 gallstone disease 57 HSCT 57 menopausal hormone therapy 57 tamoxifen therapy 57 Logistic regression analysis 57 Randomized trials 57 atypical hyperplasia 57 transrectal ultrasound guided 57 intracranial stenosis 57 logistic regression analyzes 57 vaginal hysterectomy 57 HIV HCV coinfected 57 endometrial biopsy 57 ACOSOG Z# 57 phase IIIb 57 hereditary breast cancer 57 carotid artery stenting CAS 57 RRMS patients 57 abnormal cytology 57 STRIDE PD 57 comorbid depression 57 BRCA2 mutations 57 narcolepsy cataplexy 57 HNPCC 57 prostate biopsy 57 perioperative morbidity 57 lipid lowering therapy 56 unexplained infertility 56 underwent bariatric surgery 56 BRCA gene mutations 56 genomewide association studies 56 Logistic regression 56 NATRECOR R 56 subclinical hypothyroidism 56 logistic regression models 56 perinatal depression 56 CaPSURE 56 cranial radiation 56 pelvic lymphadenectomy 56 methotrexate therapy 56 Nesiritide 56 renal biopsy 56 invasive diagnostic 56 Oncotype 56 parathyroidectomy 56 subclinical atherosclerosis 56 sentinel lymph node biopsy 56 univariate analyzes 56 CLBP 56 coronary CTA 56 neoadjuvant treatment 56 comorbid conditions 56 HER2 overexpression 56 chemoprevention trials 56 MTWA testing 56 GBA mutations 56 liver transplant recipients 56 retrospective cohort 56 Avastin adjuvant 56 prospective multicenter study 56 APOE e4 56 NATRECOR ® 56 Multivariate analysis 56 intensive statin therapy 56 abdominal hysterectomy 56 Genetic variants 56 hip resurfacing arthroplasty 56 postmenopausal hormones 56 hormone therapy HT 56 folate supplementation 56 trastuzumab Herceptin ® 56 HER2 expression 56 prelicensure 56 bone scintigraphy 56 antithrombotic therapy 56 Rheumatologists 56 comorbid disorders 56 lipid lowering drugs 56 Intervention Effectiveness CATIE 56 virological failure 56 facial transplantation 56 IMPROVE HF 56 antihypertensive therapy 56 axillary dissection 56 pharmacoeconomic 56 olaparib 56 hypofractionated radiation 56 tubal reversal 56 colorectal neoplasia 56 BRCA carriers 56 EBV infection 56 endometrial hyperplasia 56 periprocedural MI 56 preoperative MRI 56 CYP#D# genotype 56 QOPI 56 de novo AML 56 antimicrobial prophylaxis 55 AVERROES 55 warfarin dosing 55 mammographic density 55 visceral metastases 55 Sentinel Lymph Node Biopsy 55 HYVET 55 methodological limitations 55 colorectal cancer CRC 55 β blockers 55 Renal Cell Carcinoma RCC 55 cranial irradiation 55 bacterial prostatitis 55 prospective observational studies 55 anthropometric measurements 55 chromium picolinate supplementation 55 contralateral prophylactic mastectomy 55 aromatase inhibitors AIs 55 postmenopausal estrogen 55 stratifying patients 55 neurocognitive impairment 55 statin medications 55 oophorectomy 55 adjuvant radiation 55 curative therapy 55 thromboprophylaxis 55 KRAS status 55 ONTARGET 55 postmenopausal hormone replacement 55 gefitinib Iressa 55 multivariable analysis 55 prospective observational cohort 55 carotid endarterectomy surgery 55 recurrent ovarian cancer 55 Epidemiologic studies 55 nonrandomized studies 55 biologic plausibility 55 genotypic resistance 55 BRCA2 carriers 55 pCR 55 Prostate Cancer Prevention 55 R0 resection 55 AIM HIGH 55 nonpregnant women 55 retrospective cohort study 55 serum urate levels 55 herpes zoster vaccine 55 Zevalin consolidation 55 antigen PSA 55 thoracic aortic disease 55 recurrent glioblastoma multiforme 55 surgical biopsies 55 EBUS FNA 55 psychosocial distress 55 FSAD 55 coronary revascularization 55 decitabine 55 adrenalectomy 55 urolithiasis 55 Multivariate analyzes 55 comorbid illnesses 55 Cervical Pathology 55 antiretroviral naïve 55 Postmenopausal 55 sociodemographic factors 55 psychopharmacological 55 aromatase inhibitor therapy 55 BRCA gene mutation 55 antenatal depression 55 Multicenter AIDS 55 Severe Primary IGFD 55 Subgroup analysis 55 WHEL 55 aneuploidy screening 55 SLN biopsy 55 Amniocentesis 55 penicillin allergy 55 prophylactic mastectomy 55 EchoCRT 55 Cloretazine 55 LVNC 55 perioperatively 55 PSA screening 55 elective PCI 55 bowel polyps 55 unmeasured confounders 55 generalizability 55 transcatheter aortic valve implantation 55 Observational studies 55 BRCA mutations 55 carotid artery stenting 55 chronic prostatitis 55 genomic biomarker 55 BEXXAR therapeutic regimen 55 thorough QT 55 coronary calcification 55 selenium supplementation 55 recurrent UTI 55 OvaRex MAb 54 spontaneous preterm birth 54 pancreatic resection 54 imatinib resistance 54 taxane therapy 54 multivariate logistic regression 54 HIV seropositive 54 allogeneic HSCT 54 ACS NSQIP 54 CYPHER Stent 54 noncardiac chest pain 54 conditional logistic regression 54 angiographically 54 Health Initiative Observational 54 PRIMO CABG 54 CHAMPION PCI 54 prospective nonrandomized 54 DVT PE 54 Recurrence Score 54 antidepressant therapy 54 BRCA2 gene mutation 54 psychiatric comorbidity 54 primary hyperparathyroidism 54 preoperative chemotherapy 54 CAVEATS 54 anticoagulation therapy 54 TGFBR1 * 6A 54 platelet reactivity 54 MAGE A3 ASCI 54 polycystic ovary syndrome PCOS 54 p# biomarker 54 bilateral oophorectomy 54 follicular adenoma 54 postmenopausal hormone 54 Adjuvant chemotherapy 54 polycystic ovary syndrome 54 Major Depressive Disorder 54 anovulatory infertility 54 adenoma recurrence 54 ExTRACT TIMI 54 endometrial carcinoma 54 TNF antagonist 54 undergoing bariatric surgery 54 abnormal Pap 54 RCTs 54 deCODE BreastCancer TM 54 clinicopathological 54 postexposure prophylaxis 54 poor metabolizers 54 genotype phenotype 54 obese adolescents 54 vasomotor symptoms 54 Abdominal ultrasound 54 Venous thromboembolism 54 comorbid diagnoses 54 oral anticoagulation 54 antiangiogenic therapy 54 adjuvant endocrine therapy 54 postoperative morbidity 54 overnight polysomnography 54 lymph node dissection 54 ASCUS 54 pharmacological therapies 54 glucocorticoid therapy 54 laparoscopic bariatric surgery 54 Afib 54 allogeneic transplant 54 BOLDER II 54 genomewide 54 SSRI antidepressant 54 Kadan Lottick 54 lupus nephritis 54 NSQIP 54 asymptomatic PAD 54 Framingham Offspring Study 54 KIF6 carriers 54 genomic alterations 54 radioimmunotherapy RIT 54 FDG PET scans 54 ovarian malignancy 54 CALGB 54 MERLIN TIMI 54 HRQL 54 posttraumatic stress disorder PTSD 54 mammographically 54 androgen suppression 54 meta regression 54 Non inferiority 54 cognitive behavioral therapies 54 subgroup analyzes 54 Cardiotoxicity 54 angiography CCTA 54 prognostic biomarkers 54 Prostate Specific Antigen PSA 54 nonfasting triglyceride levels 54 CARE HF 54 functional neuroimaging 54 coronary arteriography 54 myocardial revascularization 54 Menopausal hormone therapy 54 estrogen progestin therapy 54 postoperative complication 54 VTE prophylaxis 54 ImmuKnow assay 54 EoE 54 PROactive study 54 BRIM3 54 adjuvant hormonal therapy 54 pancreatic adenocarcinoma 54 pretransplant 54 syndromic 54 adenomatous polyps 54 epithelial ovarian cancer 54 citalopram Celexa 54 pharmacokinetic interaction 54 lymph node biopsies 54 LNG IUS 54 TAXUS VI 54 relapsing remitting MS RRMS 54 asymptomatic carotid stenosis 54 NCCN guidelines 54 inconclusive Pap 54 PITX2 methylation 54 subthreshold depression 54 acute myocardial infarction MI 54 breast endometrial 54 pharmacologic treatments 54 Zolinza 54 Edge STudy 54 Phase IIIb study 54 meniscectomy 54 ductal carcinomas 54 thyroid dysfunction 54 eculizumab therapy 54 incidentalomas 54 hematopoietic cancers 54 telerehabilitation 54 comorbid psychiatric disorders 54 antiphospholipid antibodies 54 histologically proven 54 CHARM Added 54 postoperative pulmonary 54 metastatic lung cancer 54 prospectively enrolled 54 nonmetastatic prostate cancer 54 NAbs 54 clinico pathological 54 tumor subtype 54 coexisting illnesses 54 depressive symptomatology 54 Reynolds Risk Score 54 skin sterol 54 dose escalation phase 54 virologic failure 54 underwent CABG 54 nondepressed 54 pharmacologic stress 54 ACCORD Lipid 53 perioperative complications 53 vertebral fracture 53 Longitudinal studies 53 HeFT 53 multivariate regression analysis 53 prognostic markers 53 Sociodemographic 53 multiple logistic regression 53 intestinal polyps 53 randomized multicenter trial 53 polyp recurrence 53 CT colonography CTC 53 HER2 positive cancers 53 fragility fracture 53 OAB symptoms 53 chlamydia infection 53 premenstrual syndrome PMS 53 EUS FNA 53 stable angina 53 invasive carcinoma 53 LQTS 53 Doxil ® 53 premenopausal breast cancer 53 undergone hysterectomy 53 revision hip arthroplasty 53 advanced adenoma 53 subclinical disease 53 invasive prenatal 53 retrospective observational study 53 PPCM 53 radiographic outcomes 53 PLCO trial 53 varicoceles 53 interpersonal psychotherapy 53 hypercholesterolemic patients 53 LHRH receptor positive 53 venous thromboembolic disease 53 preoperative evaluation 53 nonpharmacologic 53 Multicenter Automatic Defibrillator Implantation 53 elective cesarean delivery 53 androgen ablation 53 longitudinal cohort study 53 thyrotropin levels 53 type 1diabetes 53 microscopic hematuria 53 postoperative chemotherapy 53 suicide ideation 53 HORIZONS AMI trial 53 spontaneous preterm delivery 53 CYP#D# inhibitor 53 intestinal biopsy 53 metaanalysis 53 neurodevelopmental outcome 53 cerebral angiography 53 OPCAB 53 Hepatocellular Carcinoma HCC 53 extracolonic findings 53 AA Amyloidosis 53 HoLEP 53 percutaneous cryoablation 53 TAXUS ARRIVE 53 LUTS 53 ovarian hyperstimulation 53 prophylactic cranial irradiation 53 chemoradiation therapy 53 carotid atherosclerosis 53 AOD# [002] 53 paricalcitol 53 chorioamnionitis 53 colorectal neoplasms 53 phytoestrogen intake 53 colorectal adenoma 53 late onset hypogonadism 53 Coronary artery bypass 53 pretest probability 53 undergone bariatric surgery 53 obstructive coronary artery 53 CT perfusion 53 neoadjuvant 53 arzoxifene 53 Wisconsin Sleep Cohort 53 clinically localized prostate 53 antibiotic prophylaxis 53 PREVENT IV 53 dysglycemia 53 mammographic screening 53 radioiodine therapy 53 prostate cancer PCa 53 intravesical therapy 53 Overactive Bladder 53 LYSTEDA 53 smoldering myeloma 53 logistic regression analysis 53 virologic response 53 POAG 53 Women Ischemia Syndrome 53 abdominal ultrasounds 53 ASCEND HF 53 atypia 53 advanced adenomas 53 OSAHS 53 suicide attempters 53 BRCA2 mutation carriers 53 renal transplants 53 PhG alpha 1 53 Unstable Angina 53 SWOG 53 therapeutic regimens 53 nomograms 53 adverse cytogenetics 53 mild gestational diabetes 53 Prostate Lung Colorectal 53 Clinical Antipsychotic Trials 53 Hepatotoxicity 53 atherosclerotic renal artery stenosis 53 androgen suppression therapy 53 Acute Decompensated Heart Failure 53 elevated ALT 53 Randomized controlled 53 grade cervical dysplasia 53 HNSCC 53 pediatric endocrinologists 53 placebo controlled clinical 53 colon resection 53 renal tumors 53 prognostic variables 53 carotid artery stenosis 53 mechanistic studies 53 Cognitive impairment 53 lipid lowering medications 53 MDRD equation 53 fluvastatin 53 hormone receptor negative 53 tryptophan depletion 53 preventative mastectomy 53 atherogenic dyslipidemia 53 recurrent miscarriages 53 menopausal symptom 53 #q# deletion syndrome 53 prospective multicentre 53 fragility fractures 53 CARDIA 53 immunosuppressive medication 53 preimplantation genetic screening 53 CIN2 + 53 invasive candidiasis 53 elevated LDL cholesterol 53 bivariate analysis 53 CANCIDAS 53 colonoscopic 53 EXJADE 53 renal denervation 53 SIMPADICO 53 thoracoscopic lobectomy 53 perioperative mortality 53 premature menopause 53 fibromyalgia syndrome 53 CIMZIA TM certolizumab pegol 53 haematologic 53 metabonomics 53 premenopausal 53 somatoform disorders 53 psychodynamic psychotherapy 53 BCIRG 53 sustained virologic response 53 varicocele 53 hypersensitivity allergic reactions 53 PHPT 53 underwent coronary angiography 53 external beam radiotherapy 53 histologically confirmed 53 neoadjuvant chemotherapy 53 screening colonoscopies 53 TOGA procedure 53 clinically insignificant 53 venous thromboembolism prophylaxis 53 lymphadenectomy 53 chronic prostatitis chronic 53 sociodemographic variables 53 coinfected patients 53 ICD implants 53 spontaneous regression 53 Femara letrozole 53 heterozygous FH 53 cytoreductive surgery 53 familial aggregation 53 Serious Adverse Events 53 thromboembolic disease 53 uncontrolled asthma 53 Colposcopy 53 Breast Cancer Treatment 53 molecular biomarkers 53 BEXXAR Therapeutic Regimen 52 solid organ transplantation 52 diagnosing ADHD 52 Liver transplantation 52 MADIT CRT 52 NT proBNP assay 52 Dr. Cliby 52 somatic mutations 52 UKPDS 52 treating uterine fibroids 52 pT2 52 Bairey Merz 52 pharmacogenetic tests 52 malignant pleural mesothelioma 52 folate intake 52 #q#.# deletion syndrome 52 adjuvant therapies 52 recurrent ischemic stroke 52 endocrinologic 52 OncotypeDX 52 extrapleural pneumonectomy 52 SRBD 52 thyroid nodules 52 FOLPI 52 Intervention Effectiveness 52 adenoidectomy 52 hormone therapy 52 Corus CAD 52 Xelox 52 Coronary artery bypass grafting 52 intracerebral haemorrhage 52 adenotonsillectomy 52 paroxetine Paxil 52 riociguat 52 FOLFIRINOX 52 Outpatient Setting 52 genetic syndromes 52 Tesmilifene 52 spirometric 52 ACRIN 52 venlafaxine Effexor 52 probands 52 polycystic ovaries 52 Normative Aging Study 52 observational cohort study 52 ELBW infants 52 nonalcoholic steatohepatitis NASH 52 grade cervical intraepithelial 52 peginterferon 52 immunochemical fecal occult 52 fibroids endometriosis 52 FFR measurements 52 ZACTIMA 52 diabetes mellitus DM 52 Erectile function 52 AGHD 52 medically inoperable 52 undergone radical prostatectomy 52 TMS Therapy 52 chronic periodontitis 52 randomizing patients 52 pelvic examinations 52 randomized Phase IIb 52 NICE guideline 52 undergoing colonoscopy 52 RTOG 52 Breast Surgeons 52 pelvic lymph node dissection 52 carotid surgery 52 convergent validity 52 placebo controlled clinical trials 52 curative resection 52 homocysteine concentrations 52 gynaecologic 52 Hurthle cell 52 mutated K ras 52 SYNTAX trial 52 beta carotene supplementation 52 F FDG PET 52 canakinumab 52 sonographic examinations 52 undergone hysterectomies 52 diagnosing Alzheimer disease 52 Lymph node 52 Afatinib 52 atrioventricular block 52 GRAVITAS trial 52 Hormone supplements 52 comorbidity 52 nondemented 52 ovarian hormones 52 differentiated thyroid 52 Heavy snorers 52 bisphosphonate therapy 52 nonmelanoma skin cancers 52 eTag assays 52 AlloMap testing 52 thyroglobulin 52 prophylactic oophorectomy 52 Sentinel node biopsy 52 STICH 52 neratinib 52 prostate carcinoma 52 nociceptive pain 52 frameless radiosurgery 52 BRCA1 52 Holt Lunstad 52 Accelerated Partial Breast Irradiation 52 benign polyps 52 NOMID 52 PDE# inhibitors 52 CSF biomarkers 52 RESOLUTE clinical 52 nodal metastasis 52 ICD therapy 52 retrospectively analyzed 52 postintervention 52 thyroidectomy 52 cochlear implantation 52 subclinical hyperthyroidism 52 vitamin D inadequacy 52 diabetic polyneuropathy 52 reflux symptoms 52 ROCHESTER Minn. Mayo Clinic 52 debulking surgery 52 phase IIb trial 52 Adjuvant therapy 52 AlloMap 52 hepatectomy 52 sentinel node biopsy 52 Dr. Relkin 52 androgen deficiency 52 APPRAISE 52 endometrial cancers 52 adverse perinatal 52 irregular menstrual cycles 52 achieved sustained virological 52 PGx 52 Univariate analysis 52 ALTTO 52 hereditary predisposition 52 FGFR2 gene 52 mammographic breast density 52 pathologic fractures 52 cediranib 52 preoperative diagnosis 52 psychiatric morbidity 52 prenatally diagnosed 52 ALI ARDS 52 Elocalcitol 52 Adenomas 52 Polycystic Ovary Syndrome 52 pharmacologic intervention 52 opioid dependent 52 ragweed allergic 52 Kaplan Meier analysis 52 Oreopoulos 52 Arch Surg 52 DEXA scan 52 PROSTVAC TM 52 elective caesarean sections 52 overactive bladder symptoms 52 VerifyNow P#Y# 52 DAPT 52 prostate adenocarcinoma 52 cytoreductive nephrectomy 52 oral bisphosphonates 52 ENESTnd 52 renal carcinoma 52 diagnostic laparoscopy 52 T2DM 52 postoperative infections 52 cardioembolic stroke 52 ELCAP 52 upper gastrointestinal endoscopy 52 colon tumors 52 metastatic RCC 52 Netherlands Cohort Study 52 neoadjuvant therapy 52 CVD mortality 52 ABO blood 52 Acute Myeloid Leukaemia AML 52 anticonvulsant medications 52 Cohort Study MACS 52 Myelodysplastic syndromes MDS 52 Neoadjuvant 52 atypical ductal hyperplasia 52 selenium intake 52 longitudinal cohort 52 undiagnosed celiac disease 52 chest radiographs 52 hepatic toxicity 52 PCPT 52 Timothy Rebbeck 52 NeuroStar TMS Therapy 52 testicular germ cell 52 nonvertebral fractures 52 decompensated heart failure 52 predictive biomarkers 52 epidural steroid injection 52 COX 2s 52 ofpatients 52 undergoing peritoneal dialysis 52 catheter angiography 52 precancerous tumors 52 ToGA 52 laparoscopically assisted 52 methodologic 52 DMIST 52 gastric adenocarcinoma 52 abnormal lipids 52 aldosterone antagonist 52 SGAs 52 Kyphon Balloon Kyphoplasty 52 carotid IMT 52 hypovitaminosis D 52 Multivariate logistic regression 52 antipsychotic prescribing 52 histological subtype 52 serum calcium levels 52 Evaluation WISE 52 postoperative delirium 52 benign proliferative breast 52 letrozole 52 lobular involution 52 rEEG 52 psychiatric outpatients 52 CAM therapies 52 digital rectal examination 52 CYP#C# [001] 52 ABSORB trial 52 carotid stenting 52 IBS sufferers 52 immunosuppressive regimens 52 atypical antipsychotic medications 52 limiting generalizability 52 pediatric malignancies 52 unmeasured factors 52 HSDD 52 B7 H3 52 attention-deficit/hyperactivity disorder ADHD 52 post natally 52 CP CPPS 52 IPAH 52 postoperative AF 52 ADPKD 52 colorectal adenomas 52 perfusion CT 52 virtual colonography 52 Haptoglobin 52 Velcade bortezomib 52 Fatty Liver Disease 52 mitochondrial toxicity 52 screening mammography 52 gastrointestinal malignancies 52 breast cancer subtypes 52 myeloproliferative disorders 52 biopsychosocial 52 osteoporotic compression fractures 52 familial hypercholesterolaemia FH 52 pre operatively 52 Alzheimer Disease AD 52 CUSTOM III 52 Valproate 52 endoscopic ultrasound EUS 52 LAGB 52 trimester ultrasound 52 abnormal pap smear 52 PCNSL 52 VATS lobectomy 52 CIPN 52 bronchopulmonary dysplasia BPD 52 trials RCTs 52 prodromal symptoms 52 ALK inhibitors 52 Bergenstal 51 BREVAGen ™ 51 VUR 51 venous blood clots 51 axillary node 51 heritable diseases 51 neurocognitive deficits 51 subtrochanteric 51 serum selenium 51 aldosterone antagonists 51 abnormal Pap smears 51 irinotecan chemotherapy 51 adnexal mass 51 antiplatelet medications 51 pharmacogenomic testing 51 presurgical 51 Schaffir 51 FeNO 51 ADHF 51 prospectively defined 51 Cochrane reviewers 51 KRAS variant 51 IgA deficiency 51 PROLARIS 51 KIF6 gene variant 51 NNRTI resistance 51 BRCA 51 cardiac revascularization 51 serum phosphate 51 serum folate concentrations 51 MRgFUS 51 NAFLD 51 lymph node involvement 51 USPSTF recommends 51 PET CT scans 51 serum estradiol 51 diagnostic angiography 51 cisplatin chemotherapy 51 immunosuppression therapy 51 antiplatelet therapy 51 polycystic ovarian syndrome 51 Fablyn 51 protease inhibitor PI 51 Doubeni 51 MADIT II 51 comorbid anxiety 51 CAMMS# 51 hormone therapy estrogen 51 faulty BRCA2 gene 51 atherothrombosis 51 isoflavone supplement 51 prostate biopsies 51 colon rectal 51 Randomized clinical trials 51 Breast Density 51 ApoE4 gene 51 IGRAs 51 statin cholesterol lowering 51 Carotid Revascularization Endarterectomy vs. 51 Laheru 51 shorter telomere length 51 Patient Registry 51 ENGAGE AF TIMI 51 Bisphosphonate 51 noscapine 51 genomewide association study 51 androgen excess 51 RSD# oral 51 serum lipid levels 51 CaP 51 postprocedure 51 postmenopausal 51 psychotherapeutic treatment 51 dose ionizing radiation 51 Hydroxyurea 51 postapproval 51 orofacial pain 51 blinded randomized controlled 51 observational cohort 51 BRCA1 mutations 51 sonographic diagnosis 51 artery embolization 51 resynchronization therapy 51 neuropsychological impairments 51 specific antigen PSA 51 FDG PET CT 51 SYNTAX 51 HIPEC 51 histologic diagnosis 51 hormonal therapies 51 TURBT 51 fetal chromosomal